Arterial Ischaemic Stroke, a more user friendly and accessible treatment modality.
Am I the only one who sees this as exciting?
Up till now the market opportunities are narrow.
This is another move to force open the rusty door leading to a massively big room.
Not yet locked in. Not yet guaranteed.
But I AM excited.
Ann: PRENUMBRA formulation completed for clinical trial use, page-2
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.87 |
Change
-0.180(1.28%) |
Mkt cap ! $695.5M | |||
| Open | High | Low | Value | Volume |
| $14.00 | $14.11 | $13.75 | $452.7K | 32.48K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 275 | $13.87 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.89 | 177 | 7 |
View Market Depth
| Last trade - 12.35pm 20/08/2024 (20 minute delay) ? |
| CUV (ASX) Chart |